DrugMapper
Browse
Therapeutic Area
CANCER (51)
CARDIOVASCULAR (45)
DENTISTRY (2)
DERMATOLOGY (31)
DIABETES DRUGS & ENDOCRINOLOGY (61)
EMERGENCY MEDICINE (3)
ENT (5)
EYE (23)
GASTROINTESTINAL (29)
HEMATOLOGY (23)
MUSCULOSKELETAL (28)
NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
PEDIATRICS (27)
PHARMACOLOGY (8)
PREGNANCY AND GYNECOLOGY (30)
RESPIRATORY (42)
RHEUMATOLOGY (19)
OTHER (1482)
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Primary Target
Target Level
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Active Pharmaceutical Ingredients (APIs)
Small Molecules
ProDrugs
Antibodies
CNS drugs
Metabolites
Search
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Target Sequence
Chemical Structure
Physicochemical Properties
Analyze
Networks
Chemical Similarity
Scaffold Similarity
KNIME workflow
Downloads
Web services
Bulk Downloads
About
DrugMapper FAQs
Data Sources
Contact Us
Display Options:
Drug type
Therapeutic Area
Route of administration
Mechanism of Action
Indication
Status
Total:
6532
CITARINOSTAT
1
Small molecule
Investigational
Unknown
Unknown
Melanoma; Multiple Myeloma; Neoplasms
Unknown
CITARINOSTAT
×
Maximum Phase:
1
First Approval:
None
UNII:
441P620G3P
Molecule Type:
Small molecule
Molecular Formula:
C24H26ClN5O3
Molecular Weight:
467.96
AlogP:
4.79
PSA:
107.45
HBD:
3.0
HBA:
#RotB:
11.0
Source:
CT-1578
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Macrophage colony stimulating factor receptor inhibitor
CT-1578
×
Maximum Phase:
1
First Approval:
None
UNII:
4T71DC0G0A
Molecule Type:
Small molecule
Molecular Formula:
C26H30N4O4
Molecular Weight:
462.55
AlogP:
4.56
PSA:
81.88
HBD:
1.0
HBA:
#RotB:
4.0
Source:
LIOTHYRONINE I 131
1
Small molecule
Investigational
Unknown
Unknown
Heart Defects, Congenital
Unknown
LIOTHYRONINE I 131
×
Maximum Phase:
1
First Approval:
None
UNII:
86AZ0G22V2
Molecule Type:
Small molecule
Molecular Formula:
C15H12I3NO4
Molecular Weight:
662.98
AlogP:
3.95
PSA:
92.78
HBD:
3.0
HBA:
#RotB:
5.0
Source:
VK-0214
1
Small molecule
Investigational
Unknown
Unknown
Adrenoleukodystrophy
Unknown
VK-0214
×
Maximum Phase:
1
First Approval:
None
UNII:
6FGG71NJ3Y
Molecule Type:
Small molecule
Molecular Formula:
C23H25O5P
Molecular Weight:
412.42
AlogP:
4.7
PSA:
86.99
HBD:
3.0
HBA:
#RotB:
7.0
Source:
L-778123
1
Small molecule
Investigational
Unknown
Unknown
Lymphoma
Unknown
L-778123
×
Maximum Phase:
1
First Approval:
None
UNII:
2A2059P49U
Molecule Type:
Small molecule
Molecular Formula:
C22H20ClN5O
Molecular Weight:
405.89
AlogP:
3.31
PSA:
65.16
HBD:
0.0
HBA:
#RotB:
5.0
Source:
THIAMPHENICOL
1
Small molecule
Investigational
Unknown
Unknown
Bacterial Infections
Unknown
THIAMPHENICOL
×
Maximum Phase:
1
First Approval:
None
UNII:
FLQ7571NPM
Molecule Type:
Small molecule
Molecular Formula:
C12H15Cl2NO5S
Molecular Weight:
356.23
AlogP:
0.4
PSA:
103.7
HBD:
3.0
HBA:
#RotB:
6.0
Source:
ABT-102
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Vanilloid receptor antagonist
ABT-102
×
Maximum Phase:
1
First Approval:
None
UNII:
J0YBN3USJN
Molecule Type:
Small molecule
Molecular Formula:
C21H24N4O
Molecular Weight:
348.45
AlogP:
4.67
PSA:
69.81
HBD:
3.0
HBA:
#RotB:
2.0
Source:
GT-0918
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
GT-0918
×
Maximum Phase:
1
First Approval:
None
UNII:
QX6O64GP40
Molecule Type:
Small molecule
Molecular Formula:
C24H19F4N5O2S
Molecular Weight:
517.51
AlogP:
5.19
PSA:
86.26
HBD:
0.0
HBA:
#RotB:
6.0
Source:
OSI-027
1
Small molecule
Investigational
Unknown
Unknown
Lymphedema; Lymphoma
Serine/threonine-protein kinase mTOR inhibitor
OSI-027
×
Maximum Phase:
1
First Approval:
None
UNII:
25MKH1SZ0M
Molecule Type:
Small molecule
Molecular Formula:
C21H22N6O3
Molecular Weight:
406.45
AlogP:
3.22
PSA:
131.42
HBD:
3.0
HBA:
#RotB:
4.0
Source:
IMD-0354
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Inhibitor of nuclear factor kappa B kinase beta subunit inhibitor
IMD-0354
×
Maximum Phase:
1
First Approval:
None
UNII:
76145IS906
Molecule Type:
Small molecule
Molecular Formula:
C15H8ClF6NO2
Molecular Weight:
383.68
AlogP:
5.34
PSA:
49.33
HBD:
2.0
HBA:
#RotB:
2.0
Source:
GOLD SODIUM THIOMALATE
1
Small molecule
Investigational
Unknown
Unknown
Lung Neoplasms; Rheumatic Diseases
Unknown
GOLD SODIUM THIOMALATE
×
Maximum Phase:
1
First Approval:
None
UNII:
E4768ZY6GM
Molecule Type:
Small molecule
Molecular Formula:
C4H5AuO4S
Molecular Weight:
346.11
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
ISOAMYL 2-CYANOACRYLATE
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
ISOAMYL 2-CYANOACRYLATE
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BFH772
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
BFH772
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
LY-3031207
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
LY-3031207
×
Maximum Phase:
1
First Approval:
None
UNII:
NQ7VQ61PBC
Molecule Type:
Small molecule
Molecular Formula:
C16H19ClN4O2
Molecular Weight:
334.81
AlogP:
2.98
PSA:
86.88
HBD:
3.0
HBA:
#RotB:
4.0
Source:
DM-1157
1
Small molecule
Investigational
Unknown
Unknown
Malaria
Unknown
DM-1157
×
Maximum Phase:
1
First Approval:
None
UNII:
6X58GJ0RMS
Molecule Type:
Small molecule
Molecular Formula:
C28H31ClN6
Molecular Weight:
487.05
AlogP:
5.32
PSA:
65.97
HBD:
2.0
HBA:
#RotB:
9.0
Source:
MK-3281
1
Small molecule
Investigational
Unknown
Unknown
Hepatitis C
Unknown
MK-3281
×
Maximum Phase:
1
First Approval:
None
UNII:
3593C180JO
Molecule Type:
Small molecule
Molecular Formula:
C29H37N3O3
Molecular Weight:
475.63
AlogP:
5.31
PSA:
57.94
HBD:
1.0
HBA:
#RotB:
6.0
Source:
2MD
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
2MD
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
L-FUCOSE
1
Small molecule
Investigational
Unknown
Unknown
Leukocyte-Adhesion Deficiency Syndrome
Unknown
L-FUCOSE
×
Maximum Phase:
1
First Approval:
None
UNII:
28RYY2IV3F
Molecule Type:
Small molecule
Molecular Formula:
C6H12O5
Molecular Weight:
164.16
AlogP:
-2.19
PSA:
90.15
HBD:
4.0
HBA:
#RotB:
0.0
Source:
LUXEPTINIB
1
Small molecule
Investigational
Unknown
Unknown
Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Myeloid, Acute; Myelodysplastic Syndromes; Neoplasms
Unknown
LUXEPTINIB
×
Maximum Phase:
1
First Approval:
None
UNII:
TQ6PBX1JU0
Molecule Type:
Small molecule
Molecular Formula:
C25H17F4N5O2
Molecular Weight:
495.44
AlogP:
5.5
PSA:
98.91
HBD:
4.0
HBA:
#RotB:
4.0
Source:
NORBUPRENORPHINE
1
Small molecule
Investigational
Unknown
Unknown
HIV Infections
Unknown
NORBUPRENORPHINE
×
Maximum Phase:
1
First Approval:
None
UNII:
7E53B4O073
Molecule Type:
Small molecule
Molecular Formula:
C25H35NO4
Molecular Weight:
413.56
AlogP:
3.29
PSA:
70.95
HBD:
3.0
HBA:
#RotB:
2.0
Source:
AS-703988
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Dual specificity mitogen-activated protein kinase kinase 1 inhibitor
AS-703988
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ZIDEBACTAM
1
Small molecule
Investigational
Unknown
Unknown
Bacterial Infections
Unknown
ZIDEBACTAM
×
Maximum Phase:
1
First Approval:
None
UNII:
YPM97423DB
Molecule Type:
Small molecule
Molecular Formula:
C13H21N5O7S
Molecular Weight:
391.41
AlogP:
-1.86
PSA:
157.38
HBD:
4.0
HBA:
#RotB:
4.0
Source:
GMI-1271
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
GMI-1271
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
TTP-607
1
Small molecule
Investigational
Unknown
Unknown
Lymphoma; Neoplasms
Serine/threonine-protein kinase Aurora inhibitor
TTP-607
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
S-3304
1
Small molecule
Investigational
Unknown
Unknown
Carcinoma, Non-Small-Cell Lung; Lung Neoplasms; Neoplasms
Unknown
S-3304
×
Maximum Phase:
1
First Approval:
None
UNII:
BK459F050X
Molecule Type:
Small molecule
Molecular Formula:
C24H20N2O4S2
Molecular Weight:
464.57
AlogP:
3.91
PSA:
99.26
HBD:
3.0
HBA:
#RotB:
6.0
Source:
BAY1436032
1
Small molecule
Investigational
Unknown
Unknown
Leukemia, Myeloid, Acute; Neoplasms
Isocitrate dehydrogenase [NADP] cytoplasmic inhibitor
BAY1436032
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C26H30F3N3O3
Molecular Weight:
489.54
AlogP:
7.08
PSA:
76.38
HBD:
2.0
HBA:
#RotB:
7.0
Source:
MIP-1095 I-123
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
MIP-1095 I-123
×
Maximum Phase:
1
First Approval:
None
UNII:
HD4940602J
Molecule Type:
Small molecule
Molecular Formula:
C19H25IN4O8
Molecular Weight:
560.33
AlogP:
1.65
PSA:
194.16
HBD:
7.0
HBA:
#RotB:
13.0
Source:
BMS-984923
1
Small molecule
Investigational
Unknown
Unknown
Alzheimer Disease
Unknown
BMS-984923
×
Maximum Phase:
1
First Approval:
None
UNII:
3I1803DK5Z
Molecule Type:
Small molecule
Molecular Formula:
C22H15ClN2O2
Molecular Weight:
374.83
AlogP:
4.66
PSA:
51.22
HBD:
1.0
HBA:
#RotB:
2.0
Source:
NEMIRALISIB
1
Small molecule
Investigational
Unknown
Unknown
Pulmonary Disease, Chronic Obstructive
PI3-kinase p110-delta subunit inhibitor
NEMIRALISIB
×
Maximum Phase:
1
First Approval:
None
UNII:
OEP8JJ3OZR
Molecule Type:
Small molecule
Molecular Formula:
C26H28N6O
Molecular Weight:
440.55
AlogP:
4.89
PSA:
76.98
HBD:
2.0
HBA:
#RotB:
5.0
Source:
FRUCTOSE
1
Small molecule
Investigational
Unknown
Unknown
Hypoglycemia; Melanoma; Non-alcoholic Fatty Liver Disease; Obesity
Unknown
FRUCTOSE
×
Maximum Phase:
1
First Approval:
None
UNII:
6YSS42VSEV
Molecule Type:
Small molecule
Molecular Formula:
C6H12O6
Molecular Weight:
180.16
AlogP:
-3.22
PSA:
110.38
HBD:
5.0
HBA:
#RotB:
2.0
Source:
RO-3201195
1
Small molecule
Investigational
Unknown
Unknown
Unknown
MAP kinase p38 alpha inhibitor
RO-3201195
×
Maximum Phase:
1
First Approval:
None
UNII:
TE3ESF890C
Molecule Type:
Small molecule
Molecular Formula:
C19H18FN3O4
Molecular Weight:
371.37
AlogP:
1.56
PSA:
110.6
HBD:
3.0
HBA:
#RotB:
7.0
Source:
GSK-690693
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
cAMP-dependent protein kinase (PKA) inhibitor
GSK-690693
×
Maximum Phase:
1
First Approval:
None
UNII:
GWH480321B
Molecule Type:
Small molecule
Molecular Formula:
C21H27N7O3
Molecular Weight:
425.49
AlogP:
1.58
PSA:
137.14
HBD:
3.0
HBA:
#RotB:
5.0
Source:
HSD-016
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
HSD-016
×
Maximum Phase:
1
First Approval:
None
UNII:
C4I13768E1
Molecule Type:
Small molecule
Molecular Formula:
C21H21F7N2O3S
Molecular Weight:
514.46
AlogP:
4.51
PSA:
60.85
HBD:
1.0
HBA:
#RotB:
4.0
Source:
OLOCROLIMUS
1
Small molecule
Investigational
Unknown
Unknown
Unknown
FK506-binding protein 1A inhibitor
OLOCROLIMUS
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
GLPG-0187
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Unknown
GLPG-0187
×
Maximum Phase:
1
First Approval:
None
UNII:
43A5P87Z4T
Molecule Type:
Small molecule
Molecular Formula:
C29H37N7O5S
Molecular Weight:
595.73
AlogP:
3.08
PSA:
158.67
HBD:
4.0
HBA:
#RotB:
10.0
Source:
1
2
…
69
70
71
72
73
74
75
…
186
187
Next »
Download Option
Close
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA